Please log in to view this page
Username
Password
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
